Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice

Gene Therapy

Volumn 15, Issue 3, 2008, Pages 155-160

  Liu, C M ^a   Yang, Z ^a   Liu, C W ^a   Wang, R ^a   Tien, P ^a   Dale, R ^b   Sun, L Q ^b  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b Oligos Etc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; MYOD PROTEIN; MYOSTATIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FEASIBILITY STUDY; FEMALE; IN VIVO STUDY; MOUSE; MUSCLE CANCER; MUSCLE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TREATMENT DURATION; UPREGULATION;

ADENOSINE TRIPHOSPHATASES; ADMINISTRATION, ORAL; ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CACHEXIA; FEMALE; GENE THERAPY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOD PROTEIN; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 38549170471     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303016     Document Type: Article

References (19)

1. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999; 129: 227S-237S.
2. Jackamn RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287: C834-C843.
3. Gonzalez-Cadavid NF, Bhasin S. Role of myostatin in metabolism. Curr Opin Clin Nutr Metab Care 2004; 7: 451-457.
4. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90.
5. Grobet L, Pirottin D, Farnir F, Poncelet D, Royo LJ, Brouwers B et al Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the Myostatin gene. Genesis 2003; 35: 227-238.
6. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002; 28: 418-421.
7. Baracos VE, DeVivo C, Hoyle DH, qoldberg AL. Activation of the ATP-ubiquitin proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 1995; 268: E996-E1006.
8. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003; 300: 965-971.
9. Magee TR, Artaza JN, Ferrini MG, Vernet D, Zuniga L, Reisz-Porszasz S et al. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med 2006; 8: 1171-1181.
10. Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J. Nutr Health Aging 2002; 6: 343-348.
11. Dasarathy S, Dodig M, Muc SM, Kalhan SC, McCullough AJ. Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1124-G1130.
12. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S et al. Organization of the human Myostatin gene and expression in healthy men and HIV infected men with muscle wasting. Proc Natl Acad Sci USA 1998; 95: 14938-44943.
13. Tsuchidak K. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Taygets Iminune Endocr Metabol Disord 2004; 4: 157-166.
14. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004; 20: 61-86.
15. Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 2003; 286: 263-275.
16. Edmondson DG, Olson EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 1989; 3 628-640.
17. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989; 86: 5434-5438.
18. Kollias HD, Perry RL, Miyake T, Aziz A, McDermott JC. Smad7 promotes and enhances skeletal muscle differentiation. Mol Cell Biol 2006; 26: 6248-6260.
19. Amthor H, Otto A, Macharia R, McKinnell I, Patel K. Myostatin imposes reversible quiescence on embryonic muscle precursors. Dev Dyn 2006; 235: 672-680.